National Health Investors (NHI) Stock Forecast & Price Target

$77.38 -0.83 (-1.06%)

(As of 11/14/2024 ET)

National Health Investors - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 7 Analyst Ratings

Sell
0

Hold
3

Buy
4

Based on 7 Wall Street analysts who have issued ratings for National Health Investors in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 3 have given a hold rating, and 4 have given a buy rating for NHI.

Consensus Price Target

$73.29
-5.29% Downside

According to the 7 analysts' twelve-month price targets for National Health Investors, the average price target is $73.29. The highest price target for NHI is $92.00, while the lowest price target for NHI is $55.00. The average price target represents a forecasted downside of -5.29% from the current price of $77.38.

Get the Latest News and Ratings for NHI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for National Health Investors and its competitors.

NHI Analyst Ratings Over Time

Type	Current Forecast 11/16/23 to 11/15/24	1 Month Ago 10/17/23 to 10/16/24	3 Months Ago 8/18/23 to 8/17/24	1 Year Ago 11/16/22 to 11/16/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	0 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$73.29	$73.29	$62.13	$53.17
Forecasted Upside	-5.29% Downside	-6.18% Downside	-16.38% Downside	0.11% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

Central Bank Abandons USD (Ad)

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.

NHI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NHI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

National Health Investors Stock vs. The Competition

Type	National Health Investors	Finance Companies	S&P 500
Consensus Rating Score	2.57	2.49	2.50
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	-5.29% Downside	10.06% Upside	8.87% Upside
News Sentiment Rating	Neutral News See Recent NHI News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/1/2024	Wells Fargo & Company 3 of 5 stars	J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$81.00 ➝ $86.00	+2.32%
9/24/2024	Bank of America 4 of 5 stars		Initiated Coverage	Buy	$92.00	+8.50%
8/30/2024	Truist Financial 2 of 5 stars		Boost Target	Hold ➝ Hold	$65.00 ➝ $78.00	-3.49%
3/18/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$64.00 ➝ $66.00	+9.33%
3/12/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$67.00	+13.53%
1/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$69.00	+27.38%
11/28/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Hold ➝ Hold	$55.00	+1.08%
9/28/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$54.00	+6.08%
9/20/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$52.00	+2.87%
3/29/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$55.00 ➝ $50.00	+0.50%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 05:29 AM ET.

NHI Forecast - Frequently Asked Questions

: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for National Health Investors is $73.29, with a high forecast of $92.00 and a low forecast of $55.00.
: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NHI shares.
: According to analysts, National Health Investors's stock has a predicted downside of -5.29% based on their 12-month stock forecasts.
: Over the previous 90 days, National Health Investors's stock had 1 downgrade by analysts.
: National Health Investors has been rated by research analysts at Bank of America, Truist Financial, and Wells Fargo & Company in the past 90 days.
: Analysts like National Health Investors more than other "finance" companies. The consensus rating for National Health Investors is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how NHI compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Central Bank Abandons USD (Ad)

Click here now to get your free 'Protect Your Wealth' Guide.

This page (NYSE:NHI) was last updated on 11/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

National Health Investors (NHI) Stock Forecast & Price Target